ENCell Co., Ltd. (KOSDAQ: A456070)
Health Care · Life Sciences Tools & Services · KR
₩5,870.00
-2.17% today · -49.5% 1Y
ENCell Co., Ltd. (KOSDAQ: A456070) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $48.16M.
Over the last twelve months the share price has lost 49.5%, trading between 4.80K and 20.95K.
Tweenvest scores ENCell Co., Ltd. across four factors: quality 38/100, value 44/100, growth 100/100. Its strongest factor is growth.
A456070 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.16M
- Revenue (TTM)
- $2.69M
- P/E
- —
- EPS
- -1,791.71
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- ₩20,950.00
- 52-week low
- ₩4,800.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.03M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pangaea Oncology, S.A.BME: PANG | $57.50M | €1.43 | 0.00% |
| Circle8 Group, Inc.NasdaqGM: CIRC | $55.22M | $0.48 | -5.45% |
| hVIVO plcAIM: HVO | $54.55M | £0.06 | 0.00% |
| Carna Biosciences, Inc.TSE: 4572 | $49.53M | ¥368.00 | -10.90% |
| Chiome Bioscience Inc.TSE: 4583 | $46.85M | ¥94.00 | -7.84% |
| Austar Lifesciences LimitedSEHK: 6118 | $45.72M | HK$0.70 | -2.78% |
| Rapid Micro Biosystems, Inc.NasdaqCM: RPID | $44.82M | $0.89 | -2.88% |
| Abnova (Taiwan) CorporationTWSE: 4133 | $42.89M | NT$22.65 | +10.76% |
Figures last refreshed Oct 11, 2026.